Item 2.02. Results of Operations and Financial Condition.

On January 9, 2020, NeuBase Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the full year ended September 30, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.

In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.






 (d) Exhibits




Exhibit Number Description

  99.1           Press Release, dated January 9, 2020, Reporting Full Year 2019
               Financial Results

© Edgar Online, source Glimpses